Projects per year
Fingerprint
Dive into the research topics where James M Angelastro is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Elimination of Carcinogen-Induced Tumor Stem Cells by ATF5 Loss of Function.
Project: Research project
-
Using Cell-Penetrant Peptides to Target ATF5 in Mouse Glioma Models
Project: Research project
-
Using Cell-Penetrant Peptides to Target ATF5 in Mouse Glioma Models
2/15/14 → 1/31/19
Project: Research project
-
Elimination of Carcinogen-Induced Tumor Stem Cells by ATF5 Loss of Function.
7/1/08 → 6/30/11
Project: Research project
-
Cell‐penetrating cebpb and cebpd leucine zipper decoys as broadly acting anti‐cancer agents
Zhou, Q., Sun, X., Pasquier, N., Jefferson, P., Nguyen, T. T. T., Siegelin, M. D., Angelastro, J. M. & Greene, L. A., May 2 2021, In: Cancers. 13, 10, 2504.Research output: Contribution to journal › Article › peer-review
Open Access -
Repurposing FDA approved drugs inhibiting mitochondrial function for targeting glioma-stem like cells
Datta, S., Sears, T., Cortopassi, G., Woolard, K. & Angelastro, J. M., Jan 2021, In: Biomedicine and Pharmacotherapy. 133, 111058.Research output: Contribution to journal › Article › peer-review
Open Access7 Scopus citations -
Cetylpyridinium chloride is a potent AMP-activated kinase (AMPK) inducer and has therapeutic potential in cancer
Allen, S. A., Datta, S., Sandoval, J., Tomilov, A., Sears, T., Woolard, K., Angelastro, J. M. & Cortopassi, G. A., Jan 2020, In: Mitochondrion. 50, p. 19-24 6 p.Research output: Contribution to journal › Article › peer-review
2 Scopus citations -
Dominant-negative ATF5 compromises cancer cell survival by targeting CEBPB and CEBPD
Sun, X., Jefferson, P., Zhou, Q., Angelastro, J. M. & Greene, L. A., Feb 1 2020, In: Molecular Cancer Research. 18, 2, p. 216-228 13 p.Research output: Contribution to journal › Article › peer-review
8 Scopus citations -
Novel mtorc1 inhibitors kill glioblastoma stem cells
Sandoval, J. A., Tomilov, A., Datta, S., Allen, S., O’Donnell, R., Sears, T., Woolard, K. D., Kovalskyy, D., Angelastro, J. M. & Cortopassi, G., Dec 2020, In: Pharmaceuticals. 13, 12, p. 1-18 18 p., 419.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations